
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Extracellular Vesicles‐Derived Hybrid Nanoplatforms for Amplified CD47 Blockade‐Based Cancer Immunotherapy
Lu Tang, Yue Yin, Yuqi Cao, et al.
Advanced Materials (2023) Vol. 35, Iss. 35
Closed Access | Times Cited: 60
Lu Tang, Yue Yin, Yuqi Cao, et al.
Advanced Materials (2023) Vol. 35, Iss. 35
Closed Access | Times Cited: 60
Showing 1-25 of 60 citing articles:
Recent advances in extracellular vesicles for therapeutic cargo delivery
Hyo In Kim, Jin Bong Park, Yin Zhu, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 4, pp. 836-849
Open Access | Times Cited: 76
Hyo In Kim, Jin Bong Park, Yin Zhu, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 4, pp. 836-849
Open Access | Times Cited: 76
Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 34
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 34
Blood–Brain Barrier‐Penetrating and Lesion‐Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy
Lu Tang, Yue Yin, Hening Liu, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 32
Lu Tang, Yue Yin, Hening Liu, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 32
Engineering therapeutical extracellular vesicles for clinical translation
Yifan Ma, Shiyan Dong, Adam Grippin, et al.
Trends in biotechnology (2024)
Closed Access | Times Cited: 25
Yifan Ma, Shiyan Dong, Adam Grippin, et al.
Trends in biotechnology (2024)
Closed Access | Times Cited: 25
Dual-targeting nanozyme combined with aPD-L1-based immunotherapy for combating cancer recurrence and metastasis
Lu Tang, Yuqi Cao, Yue Yin, et al.
Materials Today (2024) Vol. 73, pp. 79-95
Closed Access | Times Cited: 22
Lu Tang, Yuqi Cao, Yue Yin, et al.
Materials Today (2024) Vol. 73, pp. 79-95
Closed Access | Times Cited: 22
Inflammation‐Responsive Cell Membrane‐Camouflaged Nanoparticles against Liver Fibrosis via Regulating Endoplasmic Reticulum Stress and Oxidative Stress
Yang Bai, Jiaqi Chen, Sitong Zhang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Closed Access | Times Cited: 21
Yang Bai, Jiaqi Chen, Sitong Zhang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Closed Access | Times Cited: 21
Black Phosphorus Quantum Dot Loaded Bioinspired Nanoplatform Synergized with aPD-L1 for Multimode Cancer Immunotherapy
Yuqi Cao, Lu Tang, Cong Fu, et al.
Nano Letters (2024) Vol. 24, Iss. 22, pp. 6767-6777
Closed Access | Times Cited: 17
Yuqi Cao, Lu Tang, Cong Fu, et al.
Nano Letters (2024) Vol. 24, Iss. 22, pp. 6767-6777
Closed Access | Times Cited: 17
Chemoimmunotherapeutic Nanogel for Pre- and Postsurgical Treatment of Malignant Melanoma by Reprogramming Tumor-Associated Macrophages
Lu Tang, Cong Fu, Hening Liu, et al.
Nano Letters (2024) Vol. 24, Iss. 5, pp. 1717-1728
Closed Access | Times Cited: 16
Lu Tang, Cong Fu, Hening Liu, et al.
Nano Letters (2024) Vol. 24, Iss. 5, pp. 1717-1728
Closed Access | Times Cited: 16
Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
Tianchuan Zhu, Yuchen Xiao, Zhenxing Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Tianchuan Zhu, Yuchen Xiao, Zhenxing Chen, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Engineering Exosomes and Exosome-like Nanovesicles for Improving Tissue Targeting and Retention
Lanya Li, Fei Wang, Dashuai Zhu, et al.
Fundamental Research (2024)
Open Access | Times Cited: 9
Lanya Li, Fei Wang, Dashuai Zhu, et al.
Fundamental Research (2024)
Open Access | Times Cited: 9
Microneedle patch-involved local therapy synergized with immune checkpoint inhibitor for pre- and post-operative cancer treatment
Yue Yin, Lu Tang, Yuqi Cao, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 678-695
Closed Access | Times Cited: 1
Yue Yin, Lu Tang, Yuqi Cao, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 678-695
Closed Access | Times Cited: 1
Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer
Xin Luo, Kathleen M. McAndrews, Raghu Kalluri
ACS Nano (2025)
Closed Access | Times Cited: 1
Xin Luo, Kathleen M. McAndrews, Raghu Kalluri
ACS Nano (2025)
Closed Access | Times Cited: 1
CpG‐Based Nanovaccines Enhance Ovarian Cancer Immune Response by Gbp2‐Mediated Remodeling of Tumor‐Associated Macrophages
Jiaqiang Xiong, Juyuan Huang, Hanxiao Xu, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Jiaqiang Xiong, Juyuan Huang, Hanxiao Xu, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Immunomodulatory Peptides for Tumor Treatment
Yang Song, Longtianyang Lei, Xingyu Cai, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 7
Yang Song, Longtianyang Lei, Xingyu Cai, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 7
Engineered biological nanoparticles as nanotherapeutics for tumor immunomodulation
Juwita N. Rahmat, Jiayi Liu, Taili Chen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 11, pp. 5862-5903
Open Access | Times Cited: 7
Juwita N. Rahmat, Jiayi Liu, Taili Chen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 11, pp. 5862-5903
Open Access | Times Cited: 7
Size-switchable and dual-targeting nanomedicine for cancer chemoimmunotherapy by potentiating deep tumor penetration and antitumor immunity
Lu Tang, Yue Yin, Ziyao Zhang, et al.
Chemical Engineering Journal (2024) Vol. 493, pp. 152590-152590
Closed Access | Times Cited: 7
Lu Tang, Yue Yin, Ziyao Zhang, et al.
Chemical Engineering Journal (2024) Vol. 493, pp. 152590-152590
Closed Access | Times Cited: 7
Photoresponsive Multirole Nanoweapon Camouflaged by Hybrid Cell Membrane Vesicles for Efficient Antibacterial Therapy of Pseudomonas aeruginosa‐Infected Pneumonia and Wound
Hening Liu, Lu Tang, Yue Yin, et al.
Advanced Science (2024)
Open Access | Times Cited: 7
Hening Liu, Lu Tang, Yue Yin, et al.
Advanced Science (2024)
Open Access | Times Cited: 7
Engineering Versatile Bacteria‐Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy
Ziheng Luo, Cheng Xiang, Bin Feng, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 6
Ziheng Luo, Cheng Xiang, Bin Feng, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 6
Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside
Yijun Mei, Jingyi Hu, Yuanyuan Cao, et al.
Applied Materials Today (2024) Vol. 39, pp. 102341-102341
Closed Access | Times Cited: 6
Yijun Mei, Jingyi Hu, Yuanyuan Cao, et al.
Applied Materials Today (2024) Vol. 39, pp. 102341-102341
Closed Access | Times Cited: 6
Nanocarrier-Based Transdermal Drug Delivery Systems for Dermatological Therapy
Yunxiang Kang, Shuqi Zhang, Guoqi Wang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1384-1384
Open Access | Times Cited: 6
Yunxiang Kang, Shuqi Zhang, Guoqi Wang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1384-1384
Open Access | Times Cited: 6
Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
Lei Liu, Genwang Chen, Sisi Gong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Lei Liu, Genwang Chen, Sisi Gong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Exosomal non-coding RNA: A new frontier in diagnosing and treating pancreatic cancer: A review
Gengyu Sha, Wenjie Zhang, Zhengting Jiang, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130149-130149
Closed Access | Times Cited: 5
Gengyu Sha, Wenjie Zhang, Zhengting Jiang, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130149-130149
Closed Access | Times Cited: 5
Recent advances to address challenges in extracellular vesicle-based applications for lung cancer
Gaigai Huang, Wenshu Zheng, Yu Zhou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3855-3875
Open Access | Times Cited: 5
Gaigai Huang, Wenshu Zheng, Yu Zhou, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3855-3875
Open Access | Times Cited: 5
Acidity-activatable dynamic hybrid nanoplatforms derived from extracellular vesicles of M1 macrophages enhance cancer immunotherapy through synergistic triple immunotherapy
Yawen Guo, Tingting Lv, Zijie Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Yawen Guo, Tingting Lv, Zijie Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5